| abstract |
Said invention comprises obtaining a new pharmaceutical form, due to the need for an effective treatment for patients with respiratory complications, hospitalized in hospital environments, creating a pharmaceutical form with the same molecule of the drug linezolid, in this case a chemotherapy in the form of aerosol, to combat Gram positive bacteria such as Streptococcus pneumoniae, H. influenzae or Streptococcus sp, aiming at the efficacy, safety and quality of the product. |